Axsome Therapeutics, Inc. (AXSM)
232.06
-3.26
(-1.39%)
USD |
NASDAQ |
May 14, 16:00
232.06
0.00 (0.00%)
After-Hours: 18:47
Axsome Therapeutics Shareholders Equity (Quarterly) : 54.59M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Merck & Co., Inc. | 45.88B |
| Indivior Pharmaceuticals, Inc. | -144.00M |
| Eli Lilly & Co. | 31.20B |
| Esperion Therapeutics, Inc. | -307.93M |
| Ocular Therapeutix, Inc. | 581.57M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 713.61M |
| Total Liabilities (Quarterly) | 659.02M |
| Debt to Equity Ratio | 4.028 |
| Current Ratio | 1.392 |
| Net Debt Paydown Yield | -0.04% |